KAYNES.NS(KAYNES.NS)
KAYNES.NS
No analyst ratings available
No analyst price targets available for KAYNES.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $51.24B | $69.59B | $91.48B | $100.88B |
| Low | $46.21B | $62.02B | $91.12B | $90.35B |
| High | $55.21B | $79.78B | $91.84B | $112.70B |
| EBITDA Avg | $14.02B | $19.04B | $25.04B | $27.61B |
| Low | $12.65B | $16.97B | $24.94B | $24.73B |
| High | $15.11B | $21.83B | $25.13B | $30.84B |
| EBIT Avg | $12.06B | $16.38B | $21.53B | $23.74B |
| Low | $10.87B | $14.59B | $21.44B | $21.26B |
| High | $12.99B | $18.77B | $21.61B | $26.52B |
| Net Income Avg | $4.53B | $6.20B | $8.20B | $9.33B |
| Low | $3.32B | $5.04B | $6.98B | $8.07B |
| High | $5.87B | $8.93B | $11.19B | $10.76B |
| EPS Avg | $68.03 | $91.75 | $125.57 | $139.68 |
| Low | $49.69 | $75.41 | $104.48 | $120.73 |
| High | $87.87 | $133.69 | $167.51 | $160.97 |
| Analysts (Rev / EPS) | 22 / 18 | 21 / 18 | 11 / 9 | 7 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $11.41B | $10.52B | $16.22B |
| Low | $11.41B | $10.52B | $16.22B |
| High | $11.41B | $10.52B | $16.22B |
| EBITDA Avg | $3.12B | $2.88B | $4.44B |
| Low | $3.12B | $2.88B | $4.44B |
| High | $3.12B | $2.88B | $4.44B |
| EBIT Avg | $2.69B | $2.47B | $3.82B |
| Low | $2.69B | $2.47B | $3.82B |
| High | $2.69B | $2.47B | $3.82B |
| Net Income Avg | $1.14B | $1000M | $1.88B |
| Low | $1.14B | $1000M | $1.88B |
| High | $1.14B | $1000M | $1.88B |
| EPS Avg | $16.50 | $14.50 | $27.20 |
| Low | $16.50 | $14.50 | $27.20 |
| High | $16.50 | $14.50 | $27.20 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |